articleThe Lancet Diabetes & EndocrinologyFeb 5, 2024Closed access

Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

YMYiming MuXBXiao-lei BaoFGFreddy G. EliaschewitzMHMorten HansenBTBom Taeck Kim

Chinese PLA General Hospital · Novo Nordisk (Denmark) · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

109
total citations
FWCI
33.54
Percentile
100%
References
27
Citations per year

Authors

10

Topics & keywords

Topics
Keywords
  • Medicine
  • Overweight
  • Semaglutide
  • Weight management
  • Randomized controlled trial
  • Obesity
  • Population
  • Weight loss
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding